Interestingly, 65.7% (n = 44/67) of cancers from patients born in Australia or New Zealand showed EPAS1 mRNA overexpression, whereas 93.3% (n = 14/15) of cancers from patients born overseas exhibited EPAS1 mRNA overexpression (p = 0.02; Table 2). This evidence concerns the gene EPAS1 and cancer.